India’s Approval of Eli Lilly’s Tirzepatide: A Game Changer for Obesity Management
Introduction to Tirzepatide and Its Significance Tirzepatide is a novel pharmaceutical compound developed by Eli Lilly, primarily featured in their prominent medications Mounjaro and Zepbound. This active ingredient functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)…